课题基金 / 基金详情

X-RAY DIFFRACTION--NUCLEIC ACID STRUCTURES

X-RAY DIFFRACTION--NUCLEIC ACID STRUCTURES
X 射线衍射--核酸结构
批准号:
3299865
负责人:
ANDREW H WANG
金额:
$16.47万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-12-01 至 1994-11-30

项目摘要

项目成果

ANDREW H WANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal is designed to study the molecular basis of the conformational variabilities of nucleic acids, including DNA, RNA and DNA- RNA hybrid molecules by using single crystal x-ray diffraction technique as the major tool. It will be complemented by other spectroscopic studies, in particular high resolution nuclear magnetic resonance spectroscopy. Large amounts of pure DNA and RNA oligonucleotides with carefully chosen sequences will be synthesized on solid support resins either manually in solution, or by automated DNA synthesizer. Long RNA molecules will be prepared by T7 RNA polymerase system on DNA templates and they will be suitably purified for crystallization experiments. The following DNA and RNA molecular systems will be the major focus of this proposal. 1. Higher-ordered structures: triple-stranded, hairpins, cruciforms, pseudoknots, circular molecules, branched RNAs. 2. Sequence-dependent conformational analysis of double helical nucleic acids, including DNA, RNA, DNA-RNA hybrids. 3. Stable alternative nucleic acid conformations: Z-DNA, P-DNA, Hoogsteen Helix. 4. Nucleic acids with defects: Mismatch, bulge, missing base(apurine/apyrimidine), modified base (O6-mG/O4-mT), phosphotriester. The results from these structural studies both in solution and in solid states will be compared and they will be the basis for further theoretical analysis in order to fully understand the structure, dynamics and energetics of nucleic acids at the molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR MECHANISMS OF ANTICANCER DRUGS
MOLECULAR MECHANISMS OF ANTICANCER DRUGS
MOLECULAR MECHANISMS OF ANTICANCER DRUGS
MOLECULAR MECHANISMS OF ANTICANCER DRUGS
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: